GLOSSARY

Probiotic Food contains live microbes with benefit evidence, beyond merely having a live culture.

For example, record a new product's exact identity, portion and timing and assess response in training; adding several products together makes benefit or discomfort harder to attribute.

Probiotics require live microorganisms, an appropriate amount and demonstrated health benefit for the intended use. Not every fermented food or live bacterium meets that definition. Identify genus, species and strain and match the studied outcome to the goal. Evidence for one digestive or immune application does not guarantee greater strength or endurance in every athlete, nor does it make all products bearing the word equivalent.

Strain, dose, duration and study population are central to probiotic evidence. More strains or a larger colony count is not automatically better; mixtures need their own support. Temporary stool detection differs from lasting establishment or proven benefit. If used, define the goal and response beforehand. Starting immediately before competition leaves little opportunity to assess tolerance and does not reproduce a trial simply by matching a species name.

Colony-forming units estimate organisms able to grow under specified culture conditions; a cell cluster may produce one colony, so this is not an exact total-cell count. Viability at use, storage and product age matter. A manufacturing count does not establish an end-of-shelf-life amount. People with severe illness or immune impairment need separate safety assessment rather than automatically following advice intended for healthy athletes.

Phylum, family, genus, species and strain are different taxonomic levels; one strain's result cannot automatically represent its whole genus. Scientific revisions change names while older names remain in reports. Match current and historical names when comparing labels with studies. A ratio between two large phyla alone does not diagnose obesity, health or athletic readiness, and classification is not a ranking of universal benefit.

An association between microbes and health or performance does not alone establish microbial causation. Diet and training can influence both, and culture or animal findings are not direct human prescriptions. Sports-benefit claims need relevant human outcomes for the actual intervention. An axis name or biological pathway cannot replace evidence of a practical effect, especially when a product is marketed using results from a different population or formulation.

Microbial responses to food, training or supplements vary between people and depend on baseline and timing within a person. Useful personalization begins with a goal, history and response assessment; one commercial report does not provide an established precise menu. Athletes should assess performance, tolerance and adequate food alongside data. Resembling a reference population alone is not success if practical outcomes or nutritional adequacy do not improve.